Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC016844 | Panoply™ Human TUBA1B Knockdown Stable Cell Line | Inquiry |
| CSC-SC016844 | Panoply™ Human TUBA1B Over-expressing Stable Cell Line | Inquiry |
| CSC-RT0592 | Human TUBA1B Knockout Cell Line-HeLa | Inquiry |
| CSC-RT2089 | Human TUBA1B Knockout Cell Line-HepG2 | Inquiry |
| CLKO-0097 | TUBA1B KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD17130Z | Human TUBA1B adenoviral particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH437600 | shRNA set against Mouse TUBA1B (NM_011654.2) | Inquiry |
| SHL105984 | shRNA set against Human TUBA1B(NM_006082.2) | Inquiry |
| SHW015624 | shRNA set against Danio rerio TUBA1B (NM_194388) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCB156082 | Cynomolgus TUBA1B ORF clone (NM_001285253.1) | Inquiry |
| MiUTR1H-10871 | TUBA1B miRNA 3'UTR clone | Inquiry |
| CDFR004788 | Rat Tuba1b cDNA Clone(NM_001044270.1) | Inquiry |
| CDFH020608 | Human TUBA1B cDNA Clone(NM_006082.2) | Inquiry |
| MiUTR1R-06900 | TUBA1B miRNA 3'UTR clone | Inquiry |
| SKO0869 | TUBA1B Validated sgRNA vector | Inquiry |
| CDCB177099 | Danio rerio TUBA1B ORF Clone (NM_194388) | Inquiry |
| CDCB159416 | Human TUBA1B ORF clone (BC017004) | Inquiry |
| CDCR371811 | Rat Tuba1b ORF Clone(NM_001044270.1) | Inquiry |
| CDCS412549 | Human TUBA1B ORF Clone (BC017004) | Inquiry |
| CDCH096660 | Mouse Tuba1b ORF clone (NM_011654.2) | Inquiry |
| CDCS412551 | Human TUBA1B ORF Clone (BC009512) | Inquiry |
| CDCS412552 | Human TUBA1B ORF Clone (BC021564) | Inquiry |
| CDCS412553 | Human TUBA1B ORF Clone (BC071904) | Inquiry |
| CDCB180610 | Rabbit TUBA1B ORF clone (NM_001195806.1) | Inquiry |
| CDCR291968 | Human TUBA1B ORF Clone(NM_006082.2) | Inquiry |
| CDCS412550 | Human TUBA1B ORF Clone (BC000696) | Inquiry |